BIM.PA实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (8 May 2024 @ 23:35):

bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific...

Stats
今日成交量	70 365.00
平均成交量	98 976.00
市值	11.71B
EPS	€1.650 ( 2024-04-09 )
Last Dividend	€0 ( N/A )
Next Dividend	€0 ( N/A )
P/E	32.92
ATR14	€0.104 (0.10%)

音量相关性

長: -0.16 (neutral)

短: 0.03 (neutral)

Signal:(57.358) Neutral

Biomerieux SA 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Biomerieux SA 相关性 - 货币/商品

-0.57
( weak negative )

-0.63
( weak negative )

0.00
( neutral )

-0.51
( weak negative )

-0.73
( moderate negative )

-0.44
( neutral )

Biomerieux SA 财务报表

Annual	2023
营收:	€3.67B
毛利润:	€1.89B (51.34 %)
EPS:	€3.03

FY	2023
营收:	€3.67B
毛利润:	€1.89B (51.34 %)
EPS:	€3.03

FY	2022
营收:	€3.59B
毛利润:	€1.96B (54.64 %)
EPS:	€3.84

FY	2021
营收:	€3.38B
毛利润:	€1.96B (58.16 %)
EPS:	€5.09

Financial Reports:

No articles found.

Biomerieux SA

bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems, which use biological samples to diagnose infectious diseases, cardiovascular pathologies, and various cancers; and microbiological testing of manufacturing primarily for food, pharmaceutical, cosmetics, and veterinary sectors. It serves clinical and hospital laboratories, physicians, blood banks, and industrial control laboratories. The company was formerly known as B-D Mérieux. bioMérieux S.A. was founded in 1963 and is headquartered in Marcy l'Etoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.